< Back to latest news & events

Event

IAM Pharma & Biotech IP Summit 2020 – London

January 2020

Event date: 28th January 2020

HGF is a gold sponsor at IAM Pharma & Biotech IP Summit on 28th January 2020 with Partner Douglas Drysdale and Patent Director Dr Emma Longland attending the event.

The life sciences are in a period of dramatic change and innovation with developments in new technologies challenging traditional IP strategies and business models. IAM’s Pharma and Biotech IP will bring together leading in-house practitioners and expert counsel to discuss next-generation strategies for protecting and exploiting cutting-edge innovation.

HGF Partner Douglas Drysdale will be attending and joining a panel to discuss Protecting the next generation of therapies:

A wave of cutting-edge technologies – from personalised medicines to gene and cell therapies – have become the focus of innovation in the life sciences, raising new challenges for IP professionals. An expert panel will shed light on:

  • The patentability questions raised by new technologies
  • How to gain the strongest possible protection for these technologies
  • Relevant international differences

HGF Patent Director Dr Emma Longland will also be attending.

Register here

Attendees

Douglas
Drysdale

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article
See all updates